Intraocular Pressure Changes after Intravitreal Bevacizumab Injection Alone or Combination of Bevacizumab and Triamcinolone Acetonide

Authors

  • Yusuf Suleiman Tishreen Journal
  • Kahtan Jalloul
  • Nour Barakat

Abstract

Purpose: To evaluate intraocular pressure changes after intravitreal injection of Bevacizumab alone or in combination with Triamcinolone Acetonide.

Method: Our study included 63 eyes from the ophthalmology department at Tishreen University Hospital who had vascular retinal diseases. The patients were divided into two groups according to the indication of injection. The first group was injected with bevacizumab (B) at a concentration of 2.5mg/0.1ml and the second group was injected with the combination treatment of Triamcinolone Acetonide at a concentration of 2mg/0.05ml with bevacizumab (B+TA) at a concentration of 1.25mg/0.05ml.Intraocular pressure was monitored on the Goldman applanation tonometry and values ​​were recorded as follows: before injection, the second injection day, a week after injection, a month after injection and after three months.

Results: The mean values ​​of the intraocular pressure mean increased from the second day of injection in the study groups (B) and (B + TA) and the mean of the IOP values ​​before injection (13.34-13.31 mmHg) respectively, and the IOP values ​​showed the maximum in both groups after a week of the injection (17.81-17.31 mmHg) then began to decrease after a month and three months later to (17.34-17.06mmHg) and (17.6-16.75mmHg) mercury respectively, but they remained higher than they were before the injection, the number of injections had no effect on intraocular pressure.

Conclusion: intravitreal injections with both bevacizumab alone or in combination with triamcinolone acetonide resulted in a rise in intraocular pressure, and differences in pressure values ​​were statistically significant within the same group during the studied time periods but were not statistically significant between the two groups, and the number of injections had no effect on intraocular pressure.

Downloads

Published

2020-10-01

How to Cite

1.
سليمان ي, جلول ق, بركات ن. Intraocular Pressure Changes after Intravitreal Bevacizumab Injection Alone or Combination of Bevacizumab and Triamcinolone Acetonide. Tuj-hlth [Internet]. 2020Oct.1 [cited 2024Apr.26];42(4). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/9876

Issue

Vol. 42 No. 4 (2020): Tishreen University Journal for Research and Scientific Studies - Medical Sciences Series

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)

1 2 3 4 > >>